NLS Pharmaceutics is a NASDAQ listed Swiss-based company engaged in discovery and development of drug therapies for rare and complex central nervous systems disorders. Lead product candidate, Quilience® is under clinical development to treat excessive daytime sleepiness and cataplexy in narcolepsy.

Facts & figures
  • Type of organization
    Public company
  • Year of foundation
  • Number of employees in Switzerland
Key business